Gianna is an associate editor of The American Journal of Managed Care® (AJMC®). She has been working on AJMC® since 2019 and has a BA in philosophy and journalism & professional writing from The College of New Jersey.
Drugs Affecting the IL-23 Pathway May Lower Risk of Psoriatic, Inflammatory Arthritis From Psoriasis
May 10th 2023Findings show these drugs were linked with a lower risk of progression to inflammatory arthritis compared with tumor necrosis factor inhibitors, although more research is needed to confirm the finding.
Researchers Develop Prognostic Model for Survival in Patients With MF Undergoing Allo-HCT
May 8th 2023In addition to current available risk scores, the new system can help counsel patients with myelofibrosis (MF) undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT), authors wrote.
Study: Adding GLP1RA to T2D Therapy Linked With Lower MACE In Older Patients Without CVD
May 8th 2023Study authors said the findings could inform clinicians when selecting therapies for patients with type 2 diabetes (T2D). However, an editorial found the follow-up period too short and differences between the study arms too small to be meaningful.
Research Explores Causes Behind Ineffective NO Treatment for Hypoxic Pulmonary Hypertension
May 5th 2023Researchers set out to examine the effects of sodium nitroprusside on the thromboxane-mediated contraction and nitric oxide (NO)-independent relaxation pathways and on reactive oxygen species accumulation in pulmonary artery smooth muscle cells.
Review Highlights Interventions to Address Therapeutic Gaps in Heart Failure Management
April 27th 2023Accelerating the safe implementation guideline-directed medical therapy has also been shown to reduce heart failure–related morbidity and mortality, underscoring the need for more integration into current care.
Brain Volume May Serve as Biomarker of Brain Injury in Patients With Sickle Cell Disease
April 26th 2023The data highlight that silent cerebral infarcts represent just a portion of brain injury that occurs in patients with sickle cell disease (SCD), and brain volume can serve as another potential biomarker of brain injury in those with the disease.